Experiment 566728
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | SC |
| Organism | Empty organism |
| Citation | SWAIN,SM: PARKER,B: WELLSTEIN,A: LIPPMAN,ME: STEAKLEY,C: DELAP,R:. (1995). PHASE I TRIAL OF PENTOSAN POLYSULFATE.. 13(1) |
| Amount utilized | |
| Compound isolated | |
| Disease | NINETEEN PATIENTS WITH VARIOUS PHASE I TRIAL. ADULT SOLID TUMORS WERE TREATED WITH THE DRUG EVERY 6 HRS. THROMOBCYTOPENIA AND ELEVATED TRANSAMINASES AT ADOSE OF 30 MG/M2 EVER6Y 6 HRS. AN INCREASE IN ANTICOAGULANT ACTIVITY WAS OBSERVED AT A DOSE OF 22.5 MG/M2 EVERY 6 HRS. NO OBJECTIVE RESPONSES WERE SEEN AND 3 PATIENTS HAD A STABLE DISEASE FOR 16,19 AND 76 WK. |
| Dose amount | 22.5 MG |
| Number | 1 |
| Qualitative result | INACTIVE |
| Animal | HUMAN ADULT |
| Per unit | PERSON |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |